Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Antimicrobial Stewardship Program for Clostridium Difficile Infection.
- Status
- COMPLETED
- Phase
- N/A
Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Anti PD-1 Neo-adjuvant Treatment for NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Status
- TERMINATED
- Phase
- PHASE1
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning
- Status
- COMPLETED
- Phase
- NA
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
- Status
- COMPLETED
- Phase
- N/A
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Metastatic Anal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Perioperative Chemo and Pembrolizumab in Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
- Status
- COMPLETED
- Phase
- PHASE2
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
- Status
- COMPLETED
- Phase
- PHASE1
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Quality of Recovery After Reversal With Neostigmine or Sugammadex.
- Status
- COMPLETED
- Phase
- PHASE4
Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab
- Status
- COMPLETED
- Phase
- N/A